Grove AI - The Next Generation of Clinical Trials + AI Agents

​Join us for a startup demo and conversation with Grove AI, a Stanford-founded team gaining traction across the clinical trial ecosystem! Grove recently closed a 4.9 million seed round and now partners with leading pharma organizations. This session offers a grounded look at how agentic AI is used in real clinical settings to accelerate research, streamline operations and support patients at scale.

​Grove AI is a team of former Stanford Medicine researchers and AI engineers deploying agentic AI to coordinate workflows across clinical trials and patient services. Grove’s Digital Staff agent, Grace, currently supports more than fifty high priority trials for top pharmaceutical companies. Join Evan Knickerbocker, Founding Business Ops, to learn how Grove is accelerating enrollment, simplifying clinical operations, and improving patient experiences.

​Location: Tuesday, Nov 20th 3-4:20pm, LK308

​Lunch will be provided for the first 20 guests. 

​This event is part of Evidence for Us: Reimagining Clinical Trials in the Digital Age (BIOS 297). We are opening select sessions to the broader Stanford community. Seats are extremely limited, so please RSVP only if you are certain you can join.